Senna Laxative Tablet, Film Coated
FDA Label NDC 43063-838

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pd-rx Pharmaceuticals, Inc. for the product Senna Laxative (NDC 43063-838). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Purpose

Laxative

Uses

  • relieves occasional constipation (irregularity)
  • this product generally produces a bowel movement in 6 to 12 hours

Directions

  • do not exceed recommended dose
  • Age
    Starting Dose
    Maximum Dose
    adults and children 12 years of age and older
    2 tablets once a day preferably at bedtime; increase if needed, or as directed by a doctor
    4 tablets twice a day, in the morning and at bedtime
    children under 12 years
    ask a doctor
    ask a doctor

Other Information

  • Tamper Evident: Do not use if safety seal under cap is broken or missing
  • each tablet contains: calcium 20 mg, potassium 70 mg
  • store at room temperature 

Questions?

Adverse drug event call: (866) 562-2756

* Please review the disclaimer below.